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Background: Despite the available cost effective antenatal testing and treatment, syphilis and human immunodeficiency
virus (HIV) are still among common infections affecting pregnant women especially in developing countries. In Tanzania,
pregnant women are tested only once for syphilis and HIV during antenatal clinic (ANC) visits. Therefore, there are missed
opportunities for syphilis and HIV screening among those who were not tested during ANC visits and those acquiring
infections during the course of pregnancy. This study was designed to determine the syphilis and HIV seroprevalence at
delivery and seroconversion rate among pregnant women delivering at Bugando Medical Centre (BMC).
Methods: A cross sectional, hospital-based study involving pregnant women attending Bugando Medical Centre (BMC)
antenatal clinic was done from January to March 2012. Serum samples were collected and tested for HIV and syphilis
using HIV and syphilis rapid tests. Demographic and clinical data were collected using a standardized data collection tool
and analysed using STATA version 11.
Results: A total of 331 and 408 women were screened for syphilis and HIV during antenatal respectively. Of 331 women
who screened negative for syphilis at ANC, nine (2.7%) were seropositive at delivery while of 391who tested negative for
HIV during ANC eight (2%) were found to be positive at delivery. Six (1.8%) and 23 (9%) of women who did not screen
for syphilis and HIV at ANC were seropositive for syphilis and HIV at delivery respectively. There was significant difference
of seroprevalence for HIV, among women who tested negative at ANC and those who did not test at ANC (2% vs.9%,
P,<0.001). The overall prevalence of syphilis and HIV at delivery was 15 (2.3%) and 48 (7.2%) respectively. Syphilis
seropositivity at delivery was significantly associated with HIV co-infection (p < 0.001), male partner circumcision
(p = 0.011) and alcohol use among women (p < 0.001).
Conclusions: The current protocol of screening for syphilis and HIV only once during pregnancy as practiced in Tanzania
may miss women who get re-infected and seroconvert during pregnancy. Re-screening for syphilis and HIV during the
course of pregnancy and at delivery is recommended in Tanzania as it can help to identify such women and institute
appropriate treatment.
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Sexually transmitted infections (STIs) are of public
health concern in many developing countries including
Tanzania. Syphilis and HIV have been of a major con-
cern because of their impact on pregnancy outcome [1].
Syphilis is caused by the bacteria Treponema pallidum,
and is categorized as one of the genital ulcerative disease
[2,3] while HIV/AIDS is caused by human immunodefi-
ciency virus(HIV). Pregnant women are at high risk of
syphilis infection due to pregnancy induced cervical
changes, such as hyperaemia, eversion and friability
which facilitate easy transmission of syphilis leading to
spirochaetaemia [4].
The World Health Organization (WHO) estimates
that about 2 million pregnant women are infected by T.
pallidum globally with a 45-70% probability (1.2 million
cases) of vertical transmission to neonates annually [5,6].
In developing countries, 3-15% of women of child-
bearing age are infected with syphilis [3,7]. Syphilis
screening during pregnancy is important strategy to pre-
vent early fetal and neonatal death which is estimated at
620,000 worldwide annually [5].
As syphilis, HIV infection in pregnancy has become a
major concern in many developing countries. Previous
reports showed that approximately 1.5 million HIV-
positive women become pregnant each year [8] with
mother to child transmission rate estimated at 600
000 annually [9]. Previous studies showed that the in-
cidence of HIV is higher in pregnant women than in
non pregnant women [10]. During pregnancy the risk
of HIV acquisition increases due to immunological
and hormonal changes, resulting in increasing progester-
one levels which affects the mucosa of the genital tract
[11,12]. HIV infection during pregnancy has been associ-
ated with adverse fetal and maternal outcomes [13].
Early detection and treatment of syphilis and HIV in
pregnancy, especially when done before the second
trimester, is essential in preventing long term neonatal
complications and transmission of disease [3]. Even
pregnant women infected with T.pallidum four weeks
before delivery can still result in birth of an affected
newborn [4]. Moreover, HIV seronegative women who
seroconvert in late pregnancy can have maternal fetal
transmission [14]. It is recommended that syphilis screen-
ing done at the first antenatal clinic (ANC) visit in the first
trimester of pregnancy, third trimester for detection of
new infections acquired during pregnancy and at delivery
for those who missed the opportunity of antenatal screen-
ing to allow for an early diagnosis and treatment of infec-
tions in women and newborns [2]. Similarly HIV testing
in early and late pregnancy or at delivery reduces the risk
of mother to child transmission [15].
However, in developing countries, syphilis testing dur-
ing antenatal is low, ranging from 30 to 38%. As a result,few women get tested and treated for infections acquired
during pregnancy [3]. In Tanzania, women are routinely
screened for syphilis and HIV once in the entire preg-
nancy. The ANC attendance in Tanzania is more than
95% with about 60% hospital delivery. About 42% of
women attend ANC at least four times and only 15% of
women starts ANC before sixteen weeks of gestation
[16]. Thus many women are likely to progress up to de-
livery without being screened for syphilis and HIV. It is
important to establish seroprevalence of these infections
among pregnant women at initiation of pre natal care
and at delivery in order to evaluate if the single screen-
ing method at initiation of prenatal care is effective in
detection and control of these infections. In addition, in
developing countries including Tanzania, few pregnant
women get tested for syphilis during ANC visits, [17]
thus the need for screening at delivery of the non re-
active women and those who miss the opportunity of
screening during pregnancy. Such data is scarce in
Tanzania and this study aimed to provide this infor-
mation to help health policy makers plan for effective
strategies to control syphilis and HIV infections dur-
ing pregnancy.Methods
This was cross-sectional hospital based study involv-
ing women attending Bugando Medical Centre (BMC)
labour ward between January and March 2012. BMC is
a consultant and teaching hospital for the Lake and
Western zones of the United Republic of Tanzania. It is
situated along the shores of Lake Victoria in Mwanza City
with a bed capacity of 900. It is a referral centre for spe-
cialized tertiary care for eight regions: Mwanza, Geita,
Mara, Simiyu, Kagera, Shinyanga, Tabora and Kigoma. It
serves catchments population of approximately 13 million
people (http://www.bugandomedicalcentre.go.tz).
The study included pregnant women who were not
tested or tested negative for syphilis and HIV during
antenatal care visits who delivered at BMC during the
study period. Sample size for this study was calculated
by using a formula of Kelsey et al. 1996 [18]. Proportion
of exposed with disease (p1) was 3.0% [19] and propor-
tion of unexposed with disease (p2) was = 8.0% [20].
Using the above proportions, power, confidence interval
and ratio, the sample size was computed by Open
Epi- sample size calculation for cross sectional study to
be 327 in each group, making a minimum total sample
size of 654. However, in this study 678 pregnant women
were recruited.
All eligible consented pregnant women with antenatal
card (document showing number of visits and services
provided) on admission were recruited into the study
until a desired sample size was reached. Women without
Table 1 Social demographic characteristics of study
participants
Characteristics Number = 663 (%)





No formal education 36 (5.4)
Primary education 404 (60.9)
Secondary education 196 (29.6)
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from the study.
Ethical consideration
Ethical clearance was sought from the Department of
Obstetrics and Gynecology and CUHAS/BMC Research
Committee (CREC). A written informed consent was ob-
tained from each participant after explaining the aims of
the study and confidentiality was ensured throughout.
Syphilis and HIV seropositive women were advised to
attend at STI clinics with their partners for treatment,
and were also linked to pediatricians for investigations
and treatment of their babies. HIV positive women were
linked to prevention of mother to child transmission
(PMTCT) services for management.
Data, sample collection and laboratory diagnosis
A questionnaire was used to collect important parame-
ters such as socio demographic data, gynecological and
obstetric history and antenatal HIV status of study par-
ticipants. The information given by patients was verified
by crosschecking with antenatal cards information and
results for syphilis tests and HIV tests were confirmed
from the laboratory database and PMTCT unit. Venous
blood (4mls) was taken using plain vacutainer tubes
(BD, Nairobi, Kenya) and sent to the laboratory for rapid
plasma reagin (RPR) test and reactive samples were con-
firmed by Immunochromatographic (rapid) treponemal
test. Pre-test counseling and testing for HIV were done for
pregnant women who had never had HIV testing and those
screened negative at ANC visits following TANZANIA
NATIONAL GUIDELINES ALGORITHMS.
Data analysis
The collected data were sorted, entered into Microsoft
EXCEL software and then imported into STATA statis-
tical package version 11 (Stata Corp LP College Station,
Texas, USA) for consistent checks and cleaning. Analysis
was done using the same package. Results were pre-
sented in percentages and odds ratio at 95% confidence
level. Logistic regression analysis was done to test for
the association.
Results
Social demographic characteristics of study participants
During the study period, a total of 1599 pregnant
women were admitted in the labour ward. Out of 1599
pregnant women, 678 (42.4%) were recruited into the
study. The results for 663 women were analyzed. Data
for fifteen recruited participants were not analyzed be-
cause their laboratory results for syphilis were not found
due to misplacement of samples. The median age of
participants was 25 (range of 15 – 44 years). A total of
78.4% resided in the urban area while 94.6% of participantshad at least primary education (Table 1). Majority of the
participants (71.5%) attended ANC at the primary health
care facilities (dispensaries and health centre) with 61.5% of
the participants made four or more ANC visits (Table 2). A
total of 43.2% of women tested for syphilis within 16 weeks
of pregnancy. The main reason for others not to test was
lack of reagents (46.4%); other reasons include not in-
formed to test and lack of trained personnel to per-
form a test. No statistical significant difference was
obtained among those tested and those not tested
when compared to number of visits and whether they
are from urban or rural
Of 663 women enrolled, 331 (49.9%) were screened for
syphilis during antenatal visit and 408 (61.5%) were
screened for HIV during ANC. Of 663 women, 321 and
373 tested negative for syphilis and HIV during antenatal
visits respectively. Of 321 who tested negative for syph-
ilis at ANC 9 (2.7%) were seropositive at delivery while
for 373 women who screened negative for HIV at ANC
8/373 (2%) were positive at delivery. Among those who
did not test for syphilis and HIV at ANC 6 (1.8%) and
15/225 (6.6%) were positive for syphilis and HIV at deliv-
ery respectively.
The overall seroprevalence of syphilis and HIV at
delivery among study participants were 2.3% and 7.2%
respectively (Table 3). Syphilis seropositivity among
pregnant women was significantly associated with HIV
infection (p < 0.001),uncircumcised male partner (p = 0.011)
and woman’s alcohol intake(p < 0.001) (Table 4) while only
syphilis positivity was found significantly associated with
HIV infection (Table 5). In this study alcohol intake was de-
fined as taking more than three bottles per week.
Discussion
In this study, the prevalence of syphilis at delivery among
pregnant women who did not test or tested negative for
Table 2 Antenatal care profile of study participants
Characteristics Number (%)
ANC services facility in index pregnancy, n = 663
Dispensary or health centre 474 (71.5)
Hospital 189 (28.5)
GA(weeks) at first ANC visit, n = 663
≤16 297 (44.8)
>16 366 (55.2)
ANC visits in index pregnancy, n = 663
<4 visits 255 (38.5)
≥4visits 408 (61.5)
GA(weeks) at ANC syphilis screening, n = 331
≤16 143 (43.2)
>16 188 (56.8)
Reasons for not testing for syphilis at ANC, n = 332
Not informed to do a test 61 (18.4)
No reagents 154 (46.4)
No personnel to do a test 117 (35.2)
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lower than 9.3% reported in a study done in South Africa
[21]. The low prevalence of syphilis observed in this study
could be explained by good health care seeking behaviour
of the study population as it was observed that 60% of
women in this study attended ANC at least four times
which is above the national average of 42%. When com-
pared to the previous studies in the same region the preva-
lence is low. The decrease in syphilis seroprevalence has
been observed in other studies done in Mwanza region,
Kenya, Botswana and Ethiopia [22-25]. The syphilis sero-
prevalence of 1.8% among women who did not test at
ANC was also lower than the 8% and 18.2% previously re-





Syphilis test results HIV test results
Positive (%) Negative (%) Positive (%) Negative (%)
Not tested,
n = 332




9 (2.8) 322 (97.3)
Positive (%) Negative (%)
Not tested
(255)




8 (7.5) 365 (92.5)Overall there was no significant difference between sero-
prevalence of HIV at delivery among those tested during
antenatal and those tested during delivery. This has been
observed previously [26] in Nigeria.
In this study syphilis seroconversion rate was 2.7%
while that of HIV was 2%. The findings are comparable to
the study done in South Africa [21] with the same rate
for syphilis and even lower levels have been reported else-
where [27]. The HIV seroconversion rate observed in this
study was inconsistent with a previous study [28] which
reported seroconversion rate of 4.8%. This may be ex-
plained by well established HIV management and in-
creased awareness among these women. The significance
of retesting HIV late during the pregnancy is supported by
previous studies [14,29,30] which indicated that some HIV
positive babies are born to HIV seronegative mothers
tested in early pregnancy.
In this study there were no association between syph-
ilis seropositivity and maternal age during pregnancy
(p = 0.515). Similar findings have been reported else-
where in the country [31]. In addition, maternal level of
education in this study was not associated with syphilis
seropositivity in pregnancy (p = 0.353) which is incon-
sistent with previous study done in Tanzania where
syphilis seroprevalence was associated with low level of
education among pregnant women [32]. HIV seropositiv-
ity was significantly higher among syphilis seropositive
pregnant women than among syphilis seronegative
women (p < 0.001). Similar findings have been reported
in other studies in northern Tanzania and in Kenya
[33,34]. The syphilis and HIV co-infection rate of 0.9%
observed in this study was lower than co-infection rates
of 1.4% and 0.7% previously reported in other studies in
Tanzania [24,32]. Male partner circumcision in this
study was significantly associated with reduced syphilis
seropositivity (p = 0.011), similar to what has been re-
ported in study in Kenya [22]. In our study, syphilis
seropositivity was significantly associated with history of
alcohol consumption (p < 0.001), similar findings have
also been reported in previous studies [35,36]. Alcohol
intake may be one of the many health related risks such
women undertake, including concurrent multiple sexual
partnership and high rate of unprotected sex that predis-
pose to acquisition of Sexually transmitted infections
(STIs) including syphilis. Our study confirmed the associ-
ation between ulcerative STIs and HIV as it was observed
that women with syphilis were nine times more at risk of
acquiring HIV infection than those without syphilis.
One of the major limitation of this study was recruit-
ing only pregnant women attending ANC. This might
influence the seroprevalence of syphilis and HIV due to
the fact that women with risk behaviours might not wish
to attend ANC because of the routine screening of these
infections.
Table 4 Factors associated with syphilis seropositivity at delivery: Logistic regression analysis
Patient’s
characteristic
Syphilis results Univariate Multivariate
Positive n (%) Negativen (%) OR [95% CI] p-value OR [95% CI] p-value
Age
<20 (81) 1 (1.23) 80 (98.7) 1
≥20 (582) 14 (2.4) 568 (97.6) 1.97 [0.255 - 15.198] 0.515 1.53 [0.179-13.147] 0.69
Education
Informal (36) 2 (5.7) 34 (94.3) 1
Formal 13 (2.1) 614 (97.9) 2.77 [0.602 - 12.807] 0.190 2.09 [0.410-10.691] 0.37
HIV status
Negative (615) 9 (1.5) 606 (98.5) 1
Positive (48) 6 (12.5) 42 (87.5) 9.61 [3.28 - 28.35] 0.0001 9.13 [2.889-28.867] 0.0001
Partner circumcision
Circumcised (471) 6 (1.3) 465 (98.7) 1
Not circumcised (192) 9 (4.7) 183 (85.3) 3.8 [1.4 – 10.85] 0.001 3.79 [1.254-11.482] 0.01
Alcohol
No (507) 5 (1.0) 502 (99.0)
Yes (156) 10 (6.4) 146 (93.6) 6.87 [2.313 - 20.437] 0.001 6.33 [2.03-19.74] 0.001
Number of partners
Single (141) 1 (0.71) 140 (99.3) 1
Multiple (522) 14 (2.7) 508 (97.3) 3.85 [0.503 -29.5] 0.19 2.42 [0.287-20.466] 0.41
Table 5 Factors associated with HIV seropositivity at delivery: Logistic regression analysis
Patient’s
characteristic
HIV Status Univariate Multivariate
Positive n (%) Negativen (%) OR [95% CI] p-value OR [95% CI] p-value
Age
≥20 (582) 140 (6.87) 73 (90.1) 1
<20 (81) 8 (9.88) 568 (93.13) 1.49 [0.255 – 3.300] 0.515 1.61 [0.710-3.649] 0.255
Education
Formal (627) 44 (7.02) 583 (92.98) 1
Informal (36) 4 (11.1) 32 (88.9) 1.65 [0.600 - 4.894] 0.36 1.34 [0.413-4.194] 0.60
Syphilis results
Negative (648) 42 (6.48) 606 (93.52) 1
Positive (15) 6 (40.0) 9 (60.0) 9.61 [3.27 - 28.305] 0.0001 8.55 [2.718-26.198] 0.0001
Partner circumcision
Circumcised (471) 32 (6.79) 439 (93.2) 1
Not circumcised (192) 16 (8.33) 176 (91.6) 1.5 [0.667 – 2.330] 0.48 1.06 [0.554-2.054] 0.84
Alcohol
No (507) 533 (6.5) 474 (93.4)
Yes (156) 15 (9.6) 141 (90.4) 1.5 [0.806 - 2.893] 0.19 1.20 [0.606-2.415] 0.51
Number of Partners
Single (141) 8 (5.67) 133 (94.3) 1
Multiple (522) 140 (7.67) 482 (92.3) 1.37 [0.630 -3.018] 0.42 1.23 [0.556-2.748] 0.30
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Findings from this study suggest that women identified
as negative for syphilis and HIV during ANC visits may
seroconvert in the course of pregnancy and could benefit
from re-screening. Delivery at health care facility also
provides an opportunity for screening and treatment of
women who missed out during the course of pregnancy.
Seroconversion rates for syphilis and HIV observed in
this study suggest that these women may potentially
transmit these infections to the fetuses and affect the
pregnancy outcome. This in turn justifies the need for re-
screening for these infections especially in endemic areas
in the third trimester and at delivery to reduce adverse
perinatal outcomes associated with these infections.
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